Pluri Inc. (NASDAQ:PLUR – Get Free Report) was the target of a significant growth in short interest during the month of April. As of April 15th, there was short interest totalling 35,400 shares, a growth of 176.6% from the March 31st total of 12,800 shares. Currently, 0.9% of the shares of the stock are sold short. Based on an average daily volume of 29,700 shares, the days-to-cover ratio is presently 1.2 days.
Pluri Trading Up 9.4 %
PLUR stock traded up $0.46 during midday trading on Friday, reaching $5.36. 6,867 shares of the company traded hands, compared to its average volume of 24,991. The firm has a market capitalization of $27.76 million, a price-to-earnings ratio of -1.16 and a beta of 1.45. The company has a debt-to-equity ratio of 3.69, a quick ratio of 7.12 and a current ratio of 7.12. The business has a 50 day moving average of $6.42 and a 200-day moving average of $5.33. Pluri has a 52-week low of $3.45 and a 52-week high of $8.56.
Pluri (NASDAQ:PLUR – Get Free Report) last released its quarterly earnings results on Monday, February 12th. The company reported ($0.96) EPS for the quarter. The firm had revenue of $0.11 million for the quarter. Pluri had a negative return on equity of 177.94% and a negative net margin of 6,708.40%.
Hedge Funds Weigh In On Pluri
About Pluri
Pluri Inc, a biotechnology company, engages in the development of placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions. It operates in the field of regenerative medicine, food-tech, and biologics and focuses on establishing partnerships that leverage its 3D cell-based technology to additional industries that require mass cell production.
Recommended Stories
- Five stocks we like better than Pluri
- How to Invest in Small Cap StocksĀ
- 3 Stocks Leading the U.S. Agriculture Comeback
- The 3 Best Retail Stocks to Shop for in August
- How to Use Put Debit Spreads to Profit From Falling Stocks
- What is the Euro STOXX 50 Index?
- Alphabet Changes the Narrative with Its First-Ever Dividend
Receive News & Ratings for Pluri Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pluri and related companies with MarketBeat.com's FREE daily email newsletter.